Biomarkers of airway inflammation : the use of exhaled nitric oxide (FeNO) in the management of adult asthma in UK primary care
Rationale: Current asthma guidelines recommend reducing inhaled corticosteroid (ICS) therapy dose by 50% in patients with mild to moderate asthma who have demonstrated three months of good symptom control however there is evidence to suggest that this does not occur. Objectives: We tested whether ex...
| Main Author: | |
|---|---|
| Published: |
University of Nottingham
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.602954 |